Read Research Alzheimer's More' title='Share this by email.' class='social email'>           

Cognitive markers of preclinical and prodromal Alzheimer's disease in Down syndrome

Down syndrome (DS) is associated with an almost universal development of Alzheimer’s disease. Individuals with DS are therefore an important population for randomized controlled trials to prevent or delay cognitive decline, though it is essential to understand the time course of early cognitive changes. Read & Research Alzheimer’s More

Leave a Reply